TESTBANKFOR ji
lo
# #loji
PHARMACOLOGY
#lo#ji
AND THE NURSING
#lo#ji #lo#ji #lo#ji
PROCESS 8TH
#lo#ji #lo#ji
EDITION BY LILLEY
#lo#ji #lo#ji #lo#ji
SCHOLARVAULT
,Contents
Chapter #lo#ji01: #lo#jiThe #lo#jiNursing #lo#jiProcess #lo#jiand #lo#jiDrug #lo#jiTherapy ................................................................ 4
Chapter #lo#ji02: #lo#jiPharmacologic #lo#jiPrinciples .................................................................................................. 8
Chapter #lo#ji03: #lo#jiLifespan #lo#jiConsiderations .................................................................................................. 14
Chapter #lo#ji04: #lo#jiCultural, #lo#jiLegal, #lo#jiand #lo#jiEthical #lo#jiConsiderations ........................................................... 20
Chapter #lo#ji05: #lo#jiMedication #lo#jiErrors: #lo#jiPreventing #lo#jiand #lo#jiResponding .................................................... 26
Chapter #lo#ji06: #lo#jiPatient #lo#jiEducation #lo#jiand #lo#jiDrug #lo#jiTherapy..................................................................... 29
Chapter #lo#ji07: #lo#jiOver-the-Counter #lo#jiDrugs #lo#jiand #lo#jiHerbal #lo#jiand #lo#jiDietary #lo#jiSupplements....................... 34
Chapter #lo#ji08: #lo#jiGene #lo#jiTherapy #lo#jiand #lo#jiPharmacogenomics .................................................................... 38
Chapter #lo#ji09: #lo#jiPhoto #lo#jiAtlas #lo#jiof #lo#jiDrug #lo#jiAdministration ...................................................................... 41
Chapter #lo#ji10: #lo#jiAnalgesic #lo#jiDrugs............................................................................................................... 50
Chapter #lo#ji11: #lo#jiGeneral #lo#jiand #lo#jiLocal #lo#jiAnesthetics ................................................................................. 57
Chapter #lo#ji12: #lo#jiCentral #lo#jiNervous #lo#jiSystem #lo#jiDepressants #lo#jiand #lo#jiMuscle #lo#jiRelaxants .......................... 61
Chapter #lo#ji13: #lo#jiCentral #lo#jiNervous #lo#jiSystem #lo#jiStimulants #lo#jiand #lo#jiRelated #lo#jiDrugs .................................. 66
Chapter #lo#ji14: #lo#jiAntiepileptic #lo#jiDrugs ......................................................................................................... 70
Chapter #lo#ji15: #lo#jiAntiparkinson #lo#jiDrugs ........................................................................................................ 76
Chapter #lo#ji16: #lo#jiPsychotherapeutic #lo#jiDrugs ................................................................................................. 81
Chapter #lo#ji17: #lo#jiSubstance #lo#jiUse #lo#jiDisorder .............................................................................................. 88
Chapter #lo#ji18: #lo#jiAdrenergic #lo#jiDrugs ............................................................................................................ 93
Chapter #lo#ji19: #lo#jiAdrenergic-Blocking #lo#jiDrugs .............................................................................................. 98
Chapter #lo#ji20: #lo#jiCholinergic #lo#jiDrugs .......................................................................................................... 103
Chapter #lo#ji21: #lo#jiCholinergic-Blocking #lo#jiDrugs ............................................................................................ 108
Chapter #lo#ji22: #lo#jiAntihypertensive #lo#jiDrugs ................................................................................................. 113
Chapter #lo#ji23: #lo#jiAntianginal #lo#jiDrugs .......................................................................................................... 119
Chapter #lo#ji24: #lo#jiHeart #lo#jiFailure #lo#jiDrugs ................................................................................................... 125
Chapter #lo#ji25: #lo#jiAntidysrhythmic #lo#jiDrugs .................................................................................................. 131
Chapter #lo#ji26: #lo#jiCoagulation #lo#jiModifier #lo#jiDrugs ....................................................................................... 137
Chapter #lo#ji27: #lo#jiAntilipemic #lo#jiDrugs .......................................................................................................... 143
Chapter #lo#ji28: #lo#jiDiuretic #lo#jiDrugs ............................................................................................................... 148
Chapter #lo#ji29: #lo#jiFluids #lo#jiand #lo#jiElectrolytes ............................................................................................... 154
Chapter #lo#ji30: #lo#jiPituitary #lo#jiDrugs .............................................................................................................. 160
SCHOLARVAULT
,Chapter #lo#ji31: #lo#jiThyroid #lo#jiand #lo#jiAntithyroid #lo#jiDrugs ................................................................................ 163
Chapter #lo#ji32: #lo#jiAntidiabetic #lo#jiDrugs ......................................................................................................... 168
Chapter #lo#ji33: #lo#jiAdrenal #lo#jiDrugs ............................................................................................................... 177
Chapter #lo#ji34: #lo#jiWomen’s #lo#jiHealth #lo#jiDrugs .............................................................................................. 181
Chapter #lo#ji35: #lo#jiMen’s #lo#jiHealth #lo#jiDrugs ................................................................................................... 188
Chapter #lo#ji36: #lo#jiAntihistamines, #lo#jiDecongestants, #lo#jiAntitussives, #lo#jiand #lo#jiExpectorants .......................... 193
Chapter #lo#ji37: #lo#jiRespiratory #lo#jiDrugs .......................................................................................................... 198
Chapter #lo#ji38: #lo#jiAntibiotics #lo#jiPart #lo#ji1 ........................................................................................................ 204
Chapter #lo#ji39: #lo#jiAntibiotics #lo#jiPart #lo#ji2 ........................................................................................................ 211
Chapter #lo#ji40: #lo#jiAntiviral #lo#jiDrugs .............................................................................................................. 216
Chapter #lo#ji41: #lo#jiAntitubercular #lo#jiDrugs ..................................................................................................... 221
Chapter #lo#ji42: #lo#jiAntifungal #lo#jiDrugs............................................................................................................ 226
Chapter #lo#ji43: #lo#jiAntimalarial, #lo#jiAntiprotozoal, #lo#jiand #lo#jiAnthelmintic #lo#jiDrugs ........................................... 231
Chapter #lo#ji44: #lo#jiAnti-inflammatory #lo#jiand #lo#jiAntigout #lo#jiDrugs ................................................................... 236
Chapter #lo#ji45: #lo#jiAntineoplastic #lo#jiDrugs #lo#jiPart #lo#ji1: #lo#jiCancer #lo#jiOverview #lo#jiand #lo#jiCell #lo#jiCycle–Specific #lo#jiDrugs 242
Chapter #lo#ji46: #lo#jiAntineoplastic #lo#jiDrugs #lo#jiPart #lo#ji2: #lo#jiCell #lo#jiCycle–Nonspecific #lo#jiDrugs #lo#jiand #lo#jiMiscellaneous #lo#jiDrugs
.................................................................................................................................................................. 248
Chapter #lo#ji47: #lo#jiBiologic #lo#jiResponse–Modifying #lo#jiand #lo#jiAntirheumatic #lo#jiDrugs ....................................... 253
Chapter #lo#ji48: #lo#jiImmunosuppressant #lo#jiDrugs ........................................................................................... 258
Chapter #lo#ji49: #lo#jiImmunizing #lo#jiDrugs ......................................................................................................... 263
Chapter #lo#ji50: #lo#jiAcid-Controlling #lo#jiDrugs ................................................................................................... 268
Chapter #lo#ji51: #lo#jiBowel #lo#jiDisorder #lo#jiDrugs ................................................................................................ 274
Chapter #lo#ji52: #lo#jiAntiemetic #lo#jiand #lo#jiAntinausea #lo#jiDrugs ........................................................................... 281
Chapter #lo#ji53: #lo#jiVitamins #lo#jiand #lo#jiMinerals ............................................................................................... 286
Chapter #lo#ji54: #lo#jiAnemia #lo#jiDrugs ................................................................................................................ 292
Chapter #lo#ji55: #lo#jiNutritional #lo#jiSupplements............................................................................................... 299
Chapter #lo#ji56: #lo#jiDermatologic #lo#jiDrugs ...................................................................................................... 304
Chapter #lo#ji57: #lo#jiOphthalmic #lo#jiDrugs ......................................................................................................... 310
Chapter #lo#ji58: #lo#jiOtic #lo#jiDrugs ..................................................................................................................... 315
SCHOLARVAULT
, Chapter #lo#ji01: #lo#jiThe #lo#jiNursing #lo#jiProcess #lo#jiand #lo#jiDrug #lo#jiTherapy
# l o # j i # l o # j i 4
Chapter 01: The Nursing Process and Drug Therapy
MULTIPLE CHOICE
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
diagnosis?
a. Anxiety
b. Anxiety related to new drug therapy
c. Anxiety related to anxious feelings about drug therapy, as evidenced by statements
such as “I’m upset about having to test my blood sugars.”
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m
upset about having to test my blood sugars.”
ANS: D
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new
drug therapy” is missing the “as evidenced by” portion of defining characteristics. The statement
beginning “Anxiety related to anxious feelings” is incorrect because the “related to” section is
simply a restatement of the problem “anxiety,” not a separate factor related to the response.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: Nursing Diagnosis
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and
gave the medication 2 hours after the scheduled dose was due. What type of problem does this
represent?
a. “Right time”
b. “Right dose”
c. “Right route”
d. “Right medication”
ANS: A
“Right time” is correct because the medication was given more than 30 minutes after the
scheduled dose was due. “Dose” is incorrect because the dose is not related to the time the
medication administration is scheduled. “Route” is incorrect because the route is not affected.
“Medication” is incorrect because the medication ordered will not change.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
and documenting the patient’s therapeutic response to the medication. Which phase of the
nursing process do these actions illustrate?
a. Nursing diagnosis
SCHOLARVAULT
lo
# #loji
PHARMACOLOGY
#lo#ji
AND THE NURSING
#lo#ji #lo#ji #lo#ji
PROCESS 8TH
#lo#ji #lo#ji
EDITION BY LILLEY
#lo#ji #lo#ji #lo#ji
SCHOLARVAULT
,Contents
Chapter #lo#ji01: #lo#jiThe #lo#jiNursing #lo#jiProcess #lo#jiand #lo#jiDrug #lo#jiTherapy ................................................................ 4
Chapter #lo#ji02: #lo#jiPharmacologic #lo#jiPrinciples .................................................................................................. 8
Chapter #lo#ji03: #lo#jiLifespan #lo#jiConsiderations .................................................................................................. 14
Chapter #lo#ji04: #lo#jiCultural, #lo#jiLegal, #lo#jiand #lo#jiEthical #lo#jiConsiderations ........................................................... 20
Chapter #lo#ji05: #lo#jiMedication #lo#jiErrors: #lo#jiPreventing #lo#jiand #lo#jiResponding .................................................... 26
Chapter #lo#ji06: #lo#jiPatient #lo#jiEducation #lo#jiand #lo#jiDrug #lo#jiTherapy..................................................................... 29
Chapter #lo#ji07: #lo#jiOver-the-Counter #lo#jiDrugs #lo#jiand #lo#jiHerbal #lo#jiand #lo#jiDietary #lo#jiSupplements....................... 34
Chapter #lo#ji08: #lo#jiGene #lo#jiTherapy #lo#jiand #lo#jiPharmacogenomics .................................................................... 38
Chapter #lo#ji09: #lo#jiPhoto #lo#jiAtlas #lo#jiof #lo#jiDrug #lo#jiAdministration ...................................................................... 41
Chapter #lo#ji10: #lo#jiAnalgesic #lo#jiDrugs............................................................................................................... 50
Chapter #lo#ji11: #lo#jiGeneral #lo#jiand #lo#jiLocal #lo#jiAnesthetics ................................................................................. 57
Chapter #lo#ji12: #lo#jiCentral #lo#jiNervous #lo#jiSystem #lo#jiDepressants #lo#jiand #lo#jiMuscle #lo#jiRelaxants .......................... 61
Chapter #lo#ji13: #lo#jiCentral #lo#jiNervous #lo#jiSystem #lo#jiStimulants #lo#jiand #lo#jiRelated #lo#jiDrugs .................................. 66
Chapter #lo#ji14: #lo#jiAntiepileptic #lo#jiDrugs ......................................................................................................... 70
Chapter #lo#ji15: #lo#jiAntiparkinson #lo#jiDrugs ........................................................................................................ 76
Chapter #lo#ji16: #lo#jiPsychotherapeutic #lo#jiDrugs ................................................................................................. 81
Chapter #lo#ji17: #lo#jiSubstance #lo#jiUse #lo#jiDisorder .............................................................................................. 88
Chapter #lo#ji18: #lo#jiAdrenergic #lo#jiDrugs ............................................................................................................ 93
Chapter #lo#ji19: #lo#jiAdrenergic-Blocking #lo#jiDrugs .............................................................................................. 98
Chapter #lo#ji20: #lo#jiCholinergic #lo#jiDrugs .......................................................................................................... 103
Chapter #lo#ji21: #lo#jiCholinergic-Blocking #lo#jiDrugs ............................................................................................ 108
Chapter #lo#ji22: #lo#jiAntihypertensive #lo#jiDrugs ................................................................................................. 113
Chapter #lo#ji23: #lo#jiAntianginal #lo#jiDrugs .......................................................................................................... 119
Chapter #lo#ji24: #lo#jiHeart #lo#jiFailure #lo#jiDrugs ................................................................................................... 125
Chapter #lo#ji25: #lo#jiAntidysrhythmic #lo#jiDrugs .................................................................................................. 131
Chapter #lo#ji26: #lo#jiCoagulation #lo#jiModifier #lo#jiDrugs ....................................................................................... 137
Chapter #lo#ji27: #lo#jiAntilipemic #lo#jiDrugs .......................................................................................................... 143
Chapter #lo#ji28: #lo#jiDiuretic #lo#jiDrugs ............................................................................................................... 148
Chapter #lo#ji29: #lo#jiFluids #lo#jiand #lo#jiElectrolytes ............................................................................................... 154
Chapter #lo#ji30: #lo#jiPituitary #lo#jiDrugs .............................................................................................................. 160
SCHOLARVAULT
,Chapter #lo#ji31: #lo#jiThyroid #lo#jiand #lo#jiAntithyroid #lo#jiDrugs ................................................................................ 163
Chapter #lo#ji32: #lo#jiAntidiabetic #lo#jiDrugs ......................................................................................................... 168
Chapter #lo#ji33: #lo#jiAdrenal #lo#jiDrugs ............................................................................................................... 177
Chapter #lo#ji34: #lo#jiWomen’s #lo#jiHealth #lo#jiDrugs .............................................................................................. 181
Chapter #lo#ji35: #lo#jiMen’s #lo#jiHealth #lo#jiDrugs ................................................................................................... 188
Chapter #lo#ji36: #lo#jiAntihistamines, #lo#jiDecongestants, #lo#jiAntitussives, #lo#jiand #lo#jiExpectorants .......................... 193
Chapter #lo#ji37: #lo#jiRespiratory #lo#jiDrugs .......................................................................................................... 198
Chapter #lo#ji38: #lo#jiAntibiotics #lo#jiPart #lo#ji1 ........................................................................................................ 204
Chapter #lo#ji39: #lo#jiAntibiotics #lo#jiPart #lo#ji2 ........................................................................................................ 211
Chapter #lo#ji40: #lo#jiAntiviral #lo#jiDrugs .............................................................................................................. 216
Chapter #lo#ji41: #lo#jiAntitubercular #lo#jiDrugs ..................................................................................................... 221
Chapter #lo#ji42: #lo#jiAntifungal #lo#jiDrugs............................................................................................................ 226
Chapter #lo#ji43: #lo#jiAntimalarial, #lo#jiAntiprotozoal, #lo#jiand #lo#jiAnthelmintic #lo#jiDrugs ........................................... 231
Chapter #lo#ji44: #lo#jiAnti-inflammatory #lo#jiand #lo#jiAntigout #lo#jiDrugs ................................................................... 236
Chapter #lo#ji45: #lo#jiAntineoplastic #lo#jiDrugs #lo#jiPart #lo#ji1: #lo#jiCancer #lo#jiOverview #lo#jiand #lo#jiCell #lo#jiCycle–Specific #lo#jiDrugs 242
Chapter #lo#ji46: #lo#jiAntineoplastic #lo#jiDrugs #lo#jiPart #lo#ji2: #lo#jiCell #lo#jiCycle–Nonspecific #lo#jiDrugs #lo#jiand #lo#jiMiscellaneous #lo#jiDrugs
.................................................................................................................................................................. 248
Chapter #lo#ji47: #lo#jiBiologic #lo#jiResponse–Modifying #lo#jiand #lo#jiAntirheumatic #lo#jiDrugs ....................................... 253
Chapter #lo#ji48: #lo#jiImmunosuppressant #lo#jiDrugs ........................................................................................... 258
Chapter #lo#ji49: #lo#jiImmunizing #lo#jiDrugs ......................................................................................................... 263
Chapter #lo#ji50: #lo#jiAcid-Controlling #lo#jiDrugs ................................................................................................... 268
Chapter #lo#ji51: #lo#jiBowel #lo#jiDisorder #lo#jiDrugs ................................................................................................ 274
Chapter #lo#ji52: #lo#jiAntiemetic #lo#jiand #lo#jiAntinausea #lo#jiDrugs ........................................................................... 281
Chapter #lo#ji53: #lo#jiVitamins #lo#jiand #lo#jiMinerals ............................................................................................... 286
Chapter #lo#ji54: #lo#jiAnemia #lo#jiDrugs ................................................................................................................ 292
Chapter #lo#ji55: #lo#jiNutritional #lo#jiSupplements............................................................................................... 299
Chapter #lo#ji56: #lo#jiDermatologic #lo#jiDrugs ...................................................................................................... 304
Chapter #lo#ji57: #lo#jiOphthalmic #lo#jiDrugs ......................................................................................................... 310
Chapter #lo#ji58: #lo#jiOtic #lo#jiDrugs ..................................................................................................................... 315
SCHOLARVAULT
, Chapter #lo#ji01: #lo#jiThe #lo#jiNursing #lo#jiProcess #lo#jiand #lo#jiDrug #lo#jiTherapy
# l o # j i # l o # j i 4
Chapter 01: The Nursing Process and Drug Therapy
MULTIPLE CHOICE
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
diagnosis?
a. Anxiety
b. Anxiety related to new drug therapy
c. Anxiety related to anxious feelings about drug therapy, as evidenced by statements
such as “I’m upset about having to test my blood sugars.”
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m
upset about having to test my blood sugars.”
ANS: D
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new
drug therapy” is missing the “as evidenced by” portion of defining characteristics. The statement
beginning “Anxiety related to anxious feelings” is incorrect because the “related to” section is
simply a restatement of the problem “anxiety,” not a separate factor related to the response.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: Nursing Diagnosis
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and
gave the medication 2 hours after the scheduled dose was due. What type of problem does this
represent?
a. “Right time”
b. “Right dose”
c. “Right route”
d. “Right medication”
ANS: A
“Right time” is correct because the medication was given more than 30 minutes after the
scheduled dose was due. “Dose” is incorrect because the dose is not related to the time the
medication administration is scheduled. “Route” is incorrect because the route is not affected.
“Medication” is incorrect because the medication ordered will not change.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
and documenting the patient’s therapeutic response to the medication. Which phase of the
nursing process do these actions illustrate?
a. Nursing diagnosis
SCHOLARVAULT
